243 related articles for article (PubMed ID: 19489130)
1. Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels.
Sauvageau S; Thorin E; Villeneuve L; Dupuis J
Pulm Pharmacol Ther; 2009 Aug; 22(4):311-7. PubMed ID: 19489130
[TBL] [Abstract][Full Text] [Related]
2. The endothelin system in pulmonary arterial hypertension.
Galié N; Manes A; Branzi A
Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539
[TBL] [Abstract][Full Text] [Related]
3. Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.
Iglarz M; Steiner P; Wanner D; Rey M; Hess P; Clozel M
J Cardiovasc Pharmacol; 2015 Oct; 66(4):332-7. PubMed ID: 25992919
[TBL] [Abstract][Full Text] [Related]
4. Distortion of K
Angus JA; Hughes RJA; Wright CE
Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226623
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-3-dependent pulmonary vasoconstriction in monocrotaline-induced pulmonary arterial hypertension.
Sauvageau S; Thorin E; Villeneuve L; Dupuis J
Peptides; 2008 Nov; 29(11):2039-45. PubMed ID: 18771698
[TBL] [Abstract][Full Text] [Related]
6. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
7. Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pulmonary arterial hypertension.
Yu J; Taylor L; Wilson J; Comhair S; Erzurum S; Polgar P
J Cell Physiol; 2013 Feb; 228(2):322-9. PubMed ID: 22688668
[TBL] [Abstract][Full Text] [Related]
8. Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension.
Nishida M; Eshiro K; Okada Y; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2004 Aug; 44(2):187-91. PubMed ID: 15243299
[TBL] [Abstract][Full Text] [Related]
9. EndothelinB receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat.
McCulloch KM; MacLean MR
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S169-76. PubMed ID: 8587353
[TBL] [Abstract][Full Text] [Related]
10. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.
Jasmin JF; Cernacek P; Dupuis J
Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096
[TBL] [Abstract][Full Text] [Related]
11. Role of endothelin ETB receptor in the pathogenesis of monocrotaline-induced pulmonary hypertension in rats.
Nishida M; Okada Y; Akiyoshi K; Eshiro K; Takoaka M; Gariepy CE; Yanagisawa M; Matsumura Y
Eur J Pharmacol; 2004 Aug; 496(1-3):159-65. PubMed ID: 15359489
[TBL] [Abstract][Full Text] [Related]
12. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
[TBL] [Abstract][Full Text] [Related]
13. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries.
Mickley EJ; Gray GA; Webb DJ
Br J Pharmacol; 1997 Apr; 120(7):1376-82. PubMed ID: 9105715
[TBL] [Abstract][Full Text] [Related]
14. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
[TBL] [Abstract][Full Text] [Related]
15. Bucindolol attenuates the vascular remodeling of pulmonary arteries by modulating the expression of the endothelin-1 A receptor in rats with pulmonary arterial hypertension.
de Lima-Seolin BG; Hennemann MM; Fernandes RO; Colombo R; Bonetto JHP; Teixeira RB; Khaper N; Godoy AEG; Litvin IE; Sander da Rosa Araujo A; Schenkel PC; Belló-Klein A
Biomed Pharmacother; 2018 Mar; 99():704-714. PubMed ID: 29710468
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.
Harris AK; Elgebaly MM; Li W; Sachidanandam K; Ergul A
Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1213-9. PubMed ID: 18287215
[TBL] [Abstract][Full Text] [Related]
17. Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension.
Kuc RE; Carlebur M; Maguire JJ; Yang P; Long L; Toshner M; Morrell NW; Davenport AP
Life Sci; 2014 Nov; 118(2):391-6. PubMed ID: 24582810
[TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor changes in hypoxia-induced pulmonary hypertension in the newborn piglet.
Gosselin R; Gutkowska J; Baribeau J; Perreault T
Am J Physiol; 1997 Jul; 273(1 Pt 1):L72-9. PubMed ID: 9252542
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelin receptors on basal and endothelin-1-stimulated lung myofibroblast proliferation.
Préfontaine A; Calderone A; Dupuis J
Can J Physiol Pharmacol; 2008 Jun; 86(6):337-42. PubMed ID: 18516096
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of bosentan, pinacidil and nitroprusside on human pulmonary arteries: comparison with rat pulmonary arteries.
Wanstall JC; Kay CS; O'Donnell SR; Wilson K; Cole PH; Matar K
Fundam Clin Pharmacol; 1997; 11(6):584-91. PubMed ID: 9444527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
